Leadership And InnovationThe appointment of Jeffrey S. Hackman as the new CEO, with over 30 years of commercial leadership experience, brings strategic expertise to drive Fennec's growth, especially in transitioning products to the adolescent and young adult population.
Market ExpansionPositive early signals of momentum are emerging as Fennec focuses on the adolescent and young adult (AYA) market, with expectations of growth from increased penetration and reduced off-label generic use due to the new J code.
Product LaunchNorgine remains on track to launch Pedmarqsi in Germany, anticipating a first milestone of $10MM following pricing negotiations, which highlights the potential for significant revenue growth in the European market.